Tag: Heart Failure
Home-Based Palliative Care for Heart Failure May Cut Risk for Dying in Hospital
Additional benefits seen for patients with heart failure include higher rates of clinician home visits, more days spent at home
SGLT2 Inhibitors Benefit Broad Range of Heart Failure Patients
Risk for cardiovascular death, hospitalization for heart failure reduced regardless of left ventricular ejection fraction
Dapagliflozin Cuts CV Risk in Heart Failure With Preserved LVEF
Risk reduced for primary outcome of worsening heart failure or cardiovascular death
Acetazolamide Helps Treat Volume Overload in Heart Failure
Rate of successful decongestion higher with addition of acetazolamide to loop diuretic in patients with acute decompensated heart failure
Device-Measured Physical Activity Tied to Heart Failure Risk
Risk reduced for 150 to 300 min/week of moderate-intensity physical activity and for 75 to 150 min/week vigorous-intensity physical activity
Premature Menopause May Increase Risk for Heart Failure, A-Fib
Ages 45 to 49, 40 to 44, younger than 40 years versus 50 years or older at menopause associated with increased risks for heart failure, atrial fibrillation
Heart Failure-Related Deaths Up in Younger Adults in the U.S.
Black adults have a threefold higher age-adjusted, heart failure-related mortality rate versus White adults, with regional variation
Disparities Seen in LVAD Use for Heart Failure in Seniors
Authors say disparities in LVAD use by race, sex likely driven by clinician decision-making
Prognosis Worse With Overstrict Salt Restriction in HFpEF Patients
Association more predominant among those aged 70 years or younger and of non-White race
Postop A-Fib May Raise Risk for Heart Failure Hospitalization
Increased risk seen among adults without history of heart failure undergoing cardiac, noncardiac surgeries
